Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance Areas

Equivalence Trial of the Non-Bismuth 10-Day Concomitant and 14-Day Hybrid Therapies for <i>Helicobacter pylori</i> Eradication in High Clarithromycin Resistance Areas

<b>Background and aim</b>: We conducted an equivalence trial of quadruple non-bismuth “concomitant” and “hybrid” regimens for <i>H. pylori</i> eradication in a high clarithromycin resistance area. <b>Methods</b>: There were 321 treatment-naïve <i>H. pylori&l...

Full description

Bibliographic Details
Main Authors: Sotirios D. Georgopoulos, Elias Xirouchakis, Christos Liatsos, Pericles Apostolopoulos, Panagiotis Kasapidis, Beatriz Martinez-Gonzalez, Fotini Laoudi, Maria Stoupaki, Georgios Axiaris, Dionysios Sgouras, Andreas Mentis, Spyridon Michopoulos
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Antibiotics
Subjects:
<i>H. pylori</i> eradication treatment
first line
hybrid treatment
concomitant treatment
Online Access:https://www.mdpi.com/2079-6382/13/3/280

Internet

https://www.mdpi.com/2079-6382/13/3/280

Similar Items